Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Terada

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Cancer Science|January 22, 2011
SPA-1 controls the invasion and metastasis of human prostate cancerYosuke Shimizu, Yoko Hamazaki, Masakazu Hattori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burdenYoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.
Japanese Journal of Clinical Oncology|July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2022
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapyShintaro Narita, Naoki Terada, Kyoko Nomura, et al.
World Journal of Urology|March 21, 2024
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN StudyLeandro Blas, Masaki Shiota, Takuma Kato, et al.
British Journal of Cancer|August 19, 2022
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancerHiroko Kimura, Kei Mizuno, Masaki Shiota, et al.
Japanese Journal of Clinical Oncology|October 17, 2016
Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional studyKei Mizuno, Takahiro Inoue, Hidefumi Kinoshita, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Cancer Science|January 22, 2011
SPA-1 controls the invasion and metastasis of human prostate cancerYosuke Shimizu, Yoko Hamazaki, Masakazu Hattori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
Urologic Oncology|March 29, 2022
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitorsWataru Fukuokaya, Takahiro Kimura, Kazumasa Komura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burdenYoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.
Japanese Journal of Clinical Oncology|July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 25, 2022
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapyShintaro Narita, Naoki Terada, Kyoko Nomura, et al.
World Journal of Urology|March 21, 2024
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysisNobutaka Nishimura, Makito Miyake, Kota Iida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 8, 2025
Active Surveillance in Prostate Cancer With Intermediate-Risk Features: The PRIAS-JAPAN StudyLeandro Blas, Masaki Shiota, Takuma Kato, et al.
British Journal of Cancer|August 19, 2022
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancerHiroko Kimura, Kei Mizuno, Masaki Shiota, et al.
Japanese Journal of Clinical Oncology|October 17, 2016
Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional studyKei Mizuno, Takahiro Inoue, Hidefumi Kinoshita, et al.
Pageof 19